Both in Pharmaceuticals
Ensysce Biosciences vs Kiora Pharmaceuticals
Over the past year ENSC returned −75.7% and KPRX returned +2.7%; their daily moves had a correlation of 0.02.
ENSC −75.7% KPRX +2.7%Growth of $1, one year, split-adjusted
| Metric | ENSC | KPRX |
|---|---|---|
| Price | $0.5110 | $2.32 |
| Market cap | $9.9M | $10.3M |
| Today | −1.73% | −0.85% |
| 1 month | +23.3% | −11.5% |
| 6 months | +20.5% | −3.3% |
| Year to date | −44.5% | +17.8% |
| 1 year | −78.0% | −6.1% |
| Revenue growth (YoY) | −15.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −220.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | — |
| Net cash | $479.9K | $16.8M |
| Dividend yield | — | — |
| Volatility (60d) | 137.3% | 33.2% |
| Short % of float | 7.5% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).